Literature DB >> 23564337

Biologically variable ventilation in patients with acute lung injury: a pilot study.

Stephen Kowalski, Michael C McMullen, Linda G Girling, Brendan G McCarthy.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23564337      PMCID: PMC3629278          DOI: 10.1007/s12630-013-9899-5

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


× No keyword cloud information.
To the Editor, Biologically variable ventilation (BVV) involves the delivery of a fixed minute ventilation but with a variable respiratory rate and a correspondingly variable tidal volume. This type of ventilation introduces a more physiological breathing pattern than traditional types of mechanical ventilation. It has been shown to improve oxygenation and ventilation in various animal models of lung injury when compared with conventional monotonous assist control ventilation (AC).1-3 We report our preliminary experience with BVV in eight critically ill patients. With BVV, the ventilator is configured so that the product of the respiratory rate and tidal volume is constant. The average coefficient of variation in the size of tidal volume was 30%. The local Research and Ethics Board of the University of Manitoba approved this study in February 2006, and informed consent was obtained from the patients’ legal representatives. The eight patients in this study were intubated and ventilated for at least 72 hr in the medical or surgical intensive care units at the Health Sciences Centre in Winnipeg. Their baseline ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen (PaO2/FO2) was 100-300 mmHg. The study was conducted as a crossover trial with patients acting as their own control. The patients were randomized to begin with either BVV or AC, and their lungs were ventilated for a four-hour period in each mode of ventilation. The baseline tidal volume was set at 6 mL·kg−1 to comply with the adult respiratory distress syndrome (ARDS) protocol. The patients were switched to a modified Esprit® ventilator (Respironics, Carlsbad, CA, USA) that could be controlled by computer software. The computer ran a variability file that was recorded from a healthy individual and consisted of 1,489 breaths. Arterial blood gases, static lung compliance, and dead space (VD/VT) were measured every hour. After completion of the study, the patients were returned to their baseline mode of ventilation. Continuous variables were compared using repeated measures one-way analysis of variance with post hoc least squares matrices to enable between group and within group comparisons. For within group comparisons, a Bonferroni correction for multiple comparisons was used. None of the patients required an increase in FO2 or change in the level of positive end-expiratory pressure during the study. There was improvement in the oxygen index (FO2 × mean airway pressure × 100 /PaO2) after four hours of BVV compared with AC (7.1 vs 11.5 cm H2O·mmHg−1, respectively; P = 0.034) (Figure). There was no statistically significant change in arterial PaCO2 after four hours of BVV. The VD/VT ratio decreased after four hours of BVV compared with AC (0.64 vs 0.68, respectively; P = 0.017) and lung compliance improved (0.36 vs 0.34 mL·cm H2O−1·kg−1, respectively; P = 0.049).
Figure

Oxygen index vs time. The oxygen index (FO2 × mean airway pressure × 100/PaO2, expressed in cm H2O·mmHg−1) in patients ventilated with biologically variable ventilation (BVV) compared with assist control ventilation (AC). At four hours, there was an improved oxygen index with BVV compared with AC (7.1 vs 11.5 cm H2O·mmHg−1, respectively; P = 0.034)

Oxygen index vs time. The oxygen index (FO2 × mean airway pressure × 100/PaO2, expressed in cm H2O·mmHg−1) in patients ventilated with biologically variable ventilation (BVV) compared with assist control ventilation (AC). At four hours, there was an improved oxygen index with BVV compared with AC (7.1 vs 11.5 cm H2O·mmHg−1, respectively; P = 0.034) A series of mechanisms have been proposed to account for the improved ventilation with BVV in the setting of ARDS. A presumed mechanism is thought to be enhanced alveolar recruitment. Evidence for alveolar recruitment with BVV has been shown by computed tomography scanning in a porcine model of ARDS.3 If alveoli can be recruited and kept open, improved gas exchange and lung compliance would be expected with BVV. By using a variety of tidal volumes and respiratory rates, the probability of selecting the appropriate time constant for a given subpopulation of alveolar units is greatly increased. Recent editorials advocate for the role of “noisy” or physiological variability to aid ventilation of patients.4,5 This pilot project suggests that BVV may warrant further study as a mode of ventilation in patients who require controlled ventilation.
  5 in total

1.  Noisy mechanical ventilation: listen to the melody.

Authors:  David W Shimabukuro; Michael A Gropper
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

2.  Adding noise to mechanical ventilation: so obvious!

Authors:  Jérôme Allardet-Servent
Journal:  Crit Care Med       Date:  2012-09       Impact factor: 7.598

3.  Biologically variable or naturally noisy mechanical ventilation recruits atelectatic lung.

Authors:  W A Mutch; S Harms; M Ruth Graham; S E Kowalski; L G Girling; G R Lefevre
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  Resolution of pulmonary edema with variable mechanical ventilation in a porcine model of acute lung injury.

Authors:  M Ruth Graham; Harleena Gulati; Lan Kha; Linda G Girling; Andrew Goertzen; W Alan C Mutch
Journal:  Can J Anaesth       Date:  2011-06-04       Impact factor: 5.063

5.  Improved arterial oxygenation after oleic acid lung injury in the pig using a computer-controlled mechanical ventilator.

Authors:  G R Lefevre; S E Kowalski; L G Girling; D B Thiessen; W A Mutch
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

  5 in total
  8 in total

1.  Salvianolic acid B attenuates lipopolysaccharide-induced acute lung injury in rats through inhibition of apoptosis, oxidative stress and inflammation.

Authors:  Da-Hai Zhao; Yu-Jie Wu; Shu-Ting Liu; Rong-Yu Liu
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

2.  Should we breathe quiet or noisy?

Authors:  Christian Putensen; Thomas Muders
Journal:  Crit Care       Date:  2014-03-11       Impact factor: 9.097

3.  Positive end-expiratory pressure and variable ventilation in lung-healthy rats under general anesthesia.

Authors:  Luciana M Camilo; Mariana B Ávila; Luis Felipe S Cruz; Gabriel C M Ribeiro; Peter M Spieth; Andreas A Reske; Marcelo Amato; Antonio Giannella-Neto; Walter A Zin; Alysson R Carvalho
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

4.  Impact of ventilatory modes on the breathing variability in mechanically ventilated infants.

Authors:  Florent Baudin; Hau-Tieng Wu; Alice Bordessoule; Jennifer Beck; Philippe Jouvet; Martin G Frasch; Guillaume Emeriaud
Journal:  Front Pediatr       Date:  2014-11-25       Impact factor: 3.418

5.  Periodicity: A Characteristic of Heart Rate Variability Modified by the Type of Mechanical Ventilation After Acute Lung Injury.

Authors:  Anurak Thungtong; Matthew F Knoch; Frank J Jacono; Thomas E Dick; Kenneth A Loparo
Journal:  Front Physiol       Date:  2018-06-19       Impact factor: 4.566

6.  Variable Ventilation as a Diagnostic Tool for the Injured Lung.

Authors:  Bradford J Smith; Jason H T Bates
Journal:  IEEE Trans Biomed Eng       Date:  2014-04-07       Impact factor: 4.538

7.  Variable versus conventional lung protective mechanical ventilation during open abdominal surgery: study protocol for a randomized controlled trial.

Authors:  Peter M Spieth; Andreas Güldner; Christopher Uhlig; Thomas Bluth; Thomas Kiss; Marcus J Schultz; Paolo Pelosi; Thea Koch; Marcelo Gama de Abreu
Journal:  Trials       Date:  2014-05-02       Impact factor: 2.279

Review 8.  Variable ventilation from bench to bedside.

Authors:  Robert Huhle; Paolo Pelosi; Marcelo Gama de Abreu
Journal:  Crit Care       Date:  2016-03-15       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.